Showing 4311-4320 of 7009 results for "".
- Envudeucitinib Enables Durable Treat-to-Target Control in Plaque Psoriasishttps://reachmd.com/news/envudeucitinib-enables-durable-treat-to-target-control-in-plaque-psoriasis/2485542/Envudeucitinib enabled a high proportion of patients with moderate-to-severe plaque psoriasis to achieve and maintain stringent treat-to-target thresholds through one year of therapy, according to “Achievement of Treat-to-Target Thresholds With Envudeucitinib in Moderate-to-Severe Plaque Psoriasi
- Rehabilitation Strategies for Adolescent Athletes with Spondylolysishttps://reachmd.com/news/rehabilitation-strategies-for-adolescent-athletes-with-spondylolysis/2485406/Adolescent spondylolysis requires a clear rehabilitation plan: timing of physical therapy (PT) influences symptom control and return-to-play for youth athletes. Clinicians therefore face a practical question—when to begin PT to best balance pain relief, functional recovery, and safe sport r
- Dr. Amy McMichael Highlights Breakthrough Alopecia Therapieshttps://reachmd.com/news/dr-amy-mcmichael-highlights-breakthrough-alopecia-therapies/2485364/Anyone not using low-dose oral minoxidil yet has “missed the boat.” That was the message from Amy McMichael, MD, during her presentation on non-scarring hair loss at the 2026 Winter Clinical Dermatology Conference in Hawaii. Dr. McMichael, who before her presentation was named the conferen
- Revolutionizing Cancer Treatment Decisions: The Role of Early Relapse Detection with First Ascent Biomedicalhttps://reachmd.com/news/revolutionizing-cancer-treatment-decisions-the-role-of-early-relapse-detection-with-first-ascent-biomedical/2485379/When five-year-old Logan Jenner’s acute myeloid leukemia (AML) returned after years of grueling treatment and a brief remission, his family faced the same question haunting thousands of others navigating the minefield of recurrent cancers: what now? For Logan, the answer arrived not through
- Vagus Nerve Stimulation: Emerging Success in Treating-Resistant Depressionhttps://reachmd.com/news/vagus-nerve-stimulation-emerging-success-in-treating-resistant-depression/2485325/The RECOVER trial shows a durable, two-year clinical benefit from implanted vagus nerve stimulation (VNS) for adults with severe, treatment‑resistant depression—sus
- Emerging Innovations in Men's Contraceptive Technologyhttps://reachmd.com/news/innovations-mens-contraceptive-technology/2485313/YCT-529 is a non-hormonal male contraceptive in early clinical development, offering a potential new pathway for male contraception. Looking ahead, the drug’s action on spermatogene
- FDA Priority Review for Vyvgart in Seronegative MGhttps://reachmd.com/news/fda-priority-review-vyvgart-seronegative-mg/2485305/The FDA has accepted a supplemental Biologics License Application for Vyvgart (efgartigimod alfa-fcab), seeking an expanded indication for adults with AChR-Ab seronegative general
- Analysis: Ustekinumab, IL-23 Inhibitors Show Higher Drug Survival in Psoriasishttps://reachmd.com/news/analysis-ustekinumab-il-23-inhibitors-show-higher-drug-survival-in-psoriasis/2485295/A new Danish cohort study using data from the DERMBIO registry suggests ustekinumab was linked with the best 5-year survival of comparators in bionaive patients with psoriasis. The analysis included a total of 7,193 treatment
- The Role of Decipher Genomic Classifier in Prostate Cancer: Recent Validations and Clinical Implicationshttps://reachmd.com/news/the-role-of-decipher-genomic-classifier-in-prostate-cancer-recent-validations-and-clinical-implications/2485264/The VANDAAM study provides prospective validation that the Decipher genomic classifier predicts 2‑year biochemical recurrence afte
- Commentary Flags Risks in Minoxidil Use Among Older Adultshttps://reachmd.com/news/commentary-flags-risks-in-minoxidil-use-among-older-adults/2485231/In a recent commentary published in the Journal of the American Academy of Dermatology, Funda Datli Yakaryilmaz, MD, and Dursun Turkmen, MD, raise concerns about safety monitoring for low-dose oral minoxidil (LDOM) in older